OTC Markets OTCPK - Delayed Quote USD

Kineta, Inc. (KANT)

0.2300
+0.0180
+(8.49%)
At close: June 5 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
5,442
1,041
9,091
10,488
Operating Expense
17,251
21,165
42,572
20,184
13,603
Operating Income
-17,251
-15,723
-41,531
-11,093
-3,115
Net Non Operating Interest Income Expense
-99
-12
-3,728
-1,293
-4,960
Other Income Expense
-3,475
1,659
-18,194
569
963
Pretax Income
-20,825
-14,076
-63,453
-11,817
-7,112
Net Income Common Stockholders
-20,876
-14,099
-63,408
-11,817
-8,052
Diluted NI Available to Com Stockholders
-20,876
-14,099
-63,408
-11,817
-8,052
Basic EPS
-1.64
-1.28
-12.87
-2.71
-1.67
Diluted EPS
-1.64
-1.28
-12.87
-2.71
-1.67
Basic Average Shares
12,746
11,054
4,926
4,358
4,808
Diluted Average Shares
12,746
11,054
4,926
4,358
4,808
Total Operating Income as Reported
-17,251
-15,723
-41,531
-11,093
-3,115
Total Expenses
17,251
21,165
42,572
20,184
13,603
Net Income from Continuing & Discontinued Operation
-20,876
-14,099
-63,408
-11,817
-8,052
Normalized Income
-17,405
-15,681
-63,749
-13,536
-8,150
Interest Income
268
325
9
--
--
Interest Expense
367
337
3,737
1,293
4,960
Net Interest Income
-99
-12
-3,728
-1,293
-4,960
EBIT
-20,458
-13,739
-59,716
-10,524
-2,152
EBITDA
-20,453
-13,730
-59,643
-10,445
-1,994
Reconciled Depreciation
5
9
73
79
158
Net Income from Continuing Operation Net Minority Interest
-20,876
-14,099
-63,408
-11,817
-8,052
Total Unusual Items Excluding Goodwill
-3,471
1,582
341
1,719
98
Total Unusual Items
-3,471
1,582
341
1,719
98
Normalized EBITDA
-16,982
-15,312
-59,984
-12,164
-2,092
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 2/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HURA TuHURA Biosciences, Inc.
2.8100
-2.77%
 
MTVA MetaVia Inc.
0.6922
+0.30%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
ENTO Entero Therapeutics, Inc.
0.5200
+5.69%
 
PHVS Pharvaris N.V.
16.78
+4.55%
 
APRE Aprea Therapeutics, Inc.
1.7500
-3.31%
 
TCBPY TC Biopharm (Holdings) Plc
0.2500
-16.67%
 
IPSC Century Therapeutics, Inc.
0.6163
+9.47%
 
PASG Passage Bio, Inc.
0.4228
-6.04%
 
PALI Palisade Bio, Inc.
0.6967
+2.41%